| Medical and Health Sciences | Lifetime | 154 | US 84 | 99.99 |
| Biological Sciences | Lifetime | 528 | US 311 | 99.94 |
| History and Archaeology | Lifetime | 747 | US 300 | 99.00 |
| Hematology | Lifetime | 8 | US 7 | 99.97 |
| Molecular Biology | Lifetime | 121 | US 91 | 99.95 |
| Medical Genetics | Lifetime | 28 | US 18 | 99.79 |
| History of Science, Technology and Medicine | Lifetime | 112 | US 54 | 99.23 |
| Oncology | Lifetime | 385 | US 220 | 99.35 |
| Pathology and Forensic Medicine | Lifetime | 596 | US 276 | 97.37 |
| Clinical Neurology | Lifetime | 667 | US 296 | 96.66 |
| Nephrology | Lifetime | 425 | US 199 | 95.92 |
| Emergency Medicine | Lifetime | 777 | US 416 | 91.40 |
| Modern and Contemporary History | Lifetime | 976 | US 496 | 85.87 |
| Complementary and Alternative Medicine | Lifetime | 955 | US 318 | 84.53 |
| Aquatic Science and Fisheries | Lifetime | 824 | US 179 | 66.67 |
| Clinical Biochemistry | Lifetime | 917 | US 389 | 52.54 |
| Hematology | 2021-2025 | 236 | US 110 | 90.83 |
| Medical Genetics | 2021-2025 | 369 | US 173 | 72.20 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 1 | US 1 | 99.97 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 6 | US 5 | 99.95 |
| Multiple Myeloma Research and Treatments | Lifetime | 4 | US 4 | 99.97 |
| Hematological disorders and diagnostics | Lifetime | 3 | US 3 | 99.79 |
| Parathyroid Disorders and Treatments | Lifetime | 5 | US 5 | 99.80 |
| Peptidase Inhibition and Analysis | Lifetime | 14 | US 8 | 99.89 |
| Protein Degradation and Inhibitors | Lifetime | 7 | US 4 | 99.92 |
| Dermatological and Skeletal Disorders | Lifetime | 3 | US 2 | 99.74 |
| Cancer Treatment and Pharmacology | Lifetime | 36 | US 21 | 99.84 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 26 | US 16 | 99.67 |
| Blood disorders and treatments | Lifetime | 27 | US 13 | 99.36 |
| Peripheral Neuropathies and Disorders | Lifetime | 34 | US 10 | 99.55 |
| Lymphoma Diagnosis and Treatment | Lifetime | 135 | US 67 | 99.53 |
| Pancreatitis Pathology and Treatment | Lifetime | 88 | US 40 | 99.34 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 118 | US 56 | 99.28 |
| Glycosylation and Glycoproteins Research | Lifetime | 265 | US 131 | 98.94 |
| Neuroendocrine Tumor Research Advances | Lifetime | 166 | US 77 | 99.25 |
| Bone health and treatments | Lifetime | 235 | US 114 | 98.77 |
| Medical History and Innovations | Lifetime | 38 | US 24 | 97.32 |
| Ubiquitin and proteasome pathways | Lifetime | 514 | US 254 | 97.72 |
| Drug Transport and Resistance Mechanisms | Lifetime | 594 | US 240 | 97.56 |
| Cancer therapeutics and mechanisms | Lifetime | 485 | US 256 | 97.51 |
| Renal Diseases and Glomerulopathies | Lifetime | 737 | US 252 | 96.81 |
| Platelet Disorders and Treatments | Lifetime | 775 | US 305 | 96.41 |
| Viral-associated cancers and disorders | Lifetime | 803 | US 350 | 96.27 |
| Blood groups and transfusion | Lifetime | 966 | US 428 | 95.14 |
| IgG4-Related and Inflammatory Diseases | Lifetime | 188 | US 51 | 93.89 |
| Historical Medical Research and Treatments | Lifetime | 47 | US 27 | 94.27 |
| History of Medical Practice | Lifetime | 114 | US 82 | 92.23 |
| Medical History and Research | Lifetime | 288 | US 95 | 86.99 |
| Biological Research and Disease Studies | Lifetime | 66 | US 18 | 77.06 |
| History of Medicine Studies | Lifetime | 463 | US 171 | 81.18 |
| Neurology and Historical Studies | Lifetime | 955 | US 385 | 75.06 |
| International Science and Diplomacy | Lifetime | 483 | US 151 | 73.80 |
| Historical and Scientific Studies | Lifetime | 882 | US 109 | 70.83 |
| Twentieth Century Scientific Developments | Lifetime | 392 | US 178 | 58.21 |
| Multiple Myeloma Research and Treatments | 2021-2025 | 359 | US 177 | 95.15 |
| Protein Degradation and Inhibitors | 2021-2025 | 908 | US 379 | 85.10 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | 2021-2025 | 463 | US 151 | 85.18 |
| Medical History and Innovations | 2021-2025 | 77 | US 25 | 61.57 |
| History of Medical Practice | 2021-2025 | 173 | US 78 | 48.85 |
